AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32345372 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 90
Study 32345372 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 90
Study 32907384 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health smartphone application-based programme
Number of subjects: 78
Study 32907384 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 78
Study 32268896 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (SMI)
Number of subjects: 113
Study 32268896 — intervention group
Group type: COMPARATOR
Intervention: Education-based intervention (EDU)
Number of subjects: 113
Study 33387342 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative isometric exercise (handgrip device and elastic band for 8 weeks)
Number of subjects: 138
Study 33387342 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 138
Study 36319585 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive leaf extract 250 mg every 12 hours for five days
Number of subjects: 150
Study 36319585 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive leaf extract 500 mg every 12 hours for five days
Number of subjects: 150
Study 36319585 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 12 hours for five days
Number of subjects: 150
Study 33888191 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate levels of daily physical activity
Number of subjects: 9269
Study 33888191 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of daily physical activity
Number of subjects: 9269
Study 32959370 — intervention group
Group type: EXPERIMENTAL
Intervention: Create Healthy Futures program (self‐paced, 6‐lesson, web‐based intervention)
Number of subjects: 111
Study 36448278 — intervention group
Group type: EXPERIMENTAL
Intervention: Collis Curve toothbrush
Number of subjects: 16
Study 36448278 — intervention group
Group type: EXPERIMENTAL
Intervention: Superfine nano toothbrush
Number of subjects: 16
Study 36448278 — intervention group
Group type: COMPARATOR
Intervention: Conventional toothbrush (used for 4 weeks before special needs toothbrushes)
Number of subjects: 16
Study 33798493 — intervention group
Group type: EXPERIMENTAL
Intervention: ASC plus FOLFOX
Number of subjects: 162
Study 33798493 — intervention group
Group type: COMPARATOR
Intervention: ASC alone
Number of subjects: 162
Study 34600945 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 days meat-free pledge
Number of subjects: 325
Study 34600945 — intervention group
Group type: COMPARATOR
Intervention: Control group (not pledging)
Number of subjects: 325
Study 34600945 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 325
Study 33534773 — intervention group
Group type: EXPERIMENTAL
Intervention: Latrines (case-houses)
Number of subjects: 48
Study 33534773 — intervention group
Group type: COMPARATOR
Intervention: Flushing toilets (control-houses)
Number of subjects: 48
Study 36216656 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-led lesson
Number of subjects: 104
Study 36216656 — intervention group
Group type: COMPARATOR
Intervention: IVR lesson
Number of subjects: 104
Study 34399702 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip arthroscopy
Number of subjects: 99
Study 34399702 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapist-led management (Personalised Hip Therapy - PHT)
Number of subjects: 99
Study 32000729 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P (SSTP) parenting therapy (nine weeks, six group sessions and three individualised sessions) in addition to Treatment as Usual
Number of subjects: 258
Study 32000729 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual only (other available services in each location)
Number of subjects: 258
Study 33359814 — intervention group
Group type: EXPERIMENTAL
Intervention: Proficiency-Based Progression (PBP) curriculum for arthroscopic Bankart repair (ABR)
Number of subjects: 18
Study 33359814 — intervention group
Group type: EXPERIMENTAL
Intervention: Proficiency-Based Progression (PBP) curriculum for arthroscopic rotator cuff repair (ARCR)
Number of subjects: 18
Study 33359814 — intervention group
Group type: COMPARATOR
Intervention: Precourse baseline performance
Number of subjects: 18
Study 33248070 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCM (computer-aided diagnostic model)
Number of subjects: 295
Study 33248070 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCM
Number of subjects: 295
Study 35812678 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (administered in eight sessions biweekly over 4 weeks)
Number of subjects: 211
Study 35812678 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 211
Study 32711058 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial co-infection (estimated on presentation)
Number of subjects: 3338
Study 32711058 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary bacterial infection
Number of subjects: 3338
Study 32711058 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall bacterial infection
Number of subjects: 3338
Study 32711058 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial infection in critically ill patients
Number of subjects: 3338
Study 32711058 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients receiving antibiotics
Number of subjects: 3338
Study 35738969 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG intradermal vaccine
Number of subjects: 299
Study 35738969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 32997095 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding TAVR (iliofemoral access)
Number of subjects: 713
Study 32997095 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 713
Study 32997095 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding TAVR (noniliofemoral access)
Number of subjects: 713
Study 32997095 — intervention group
Group type: COMPARATOR
Intervention: SAVR (noniliofemoral access)
Number of subjects: 713
Study 33733257 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Ex mobile application (30 minutes of self-directed learning)
Number of subjects: 45
Study 33733257 — intervention group
Group type: COMPARATOR
Intervention: Control group (no use of mobile application)
Number of subjects: 45
Study 36975195 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week MTM
Number of subjects: 650
Study 36975195 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week MTM
Number of subjects: 650
Study 36975195 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 2-week and 4-week MTM
Number of subjects: 650
Study 33486385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT)
Number of subjects: 108
Study 33486385 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108
Study 33486385 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 108
Study 33486385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT) and Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108
Study 32761337 — intervention group
Group type: EXPERIMENTAL
Intervention: Guilingji Capsules (GLJC) 0.6 g once a day and 19.2 mg of Gingko biloba extract mimetic 3 times a day
Number of subjects: 348
Study 32761337 — intervention group
Group type: COMPARATOR
Intervention: Guilingji Capsules (GLJC) mimetic 0.6 g once a day and 19.2 mg of Gingko biloba extract in tablet form 3 times a day
Number of subjects: 348
Study 36161864 — intervention group
Group type: EXPERIMENTAL
Intervention: OMEGA group (n = 14; 2234 mg of EPA and 916 mg of DHA daily)
Number of subjects: 26
Study 36161864 — intervention group
Group type: COMPARATOR
Intervention: MCT group (n = 12; 4000 mg of MCT daily)
Number of subjects: 26
Study 36161864 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined data from both groups
Number of subjects: 26
Study 33368399 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected radiomic features for larger lesions
Number of subjects: 150
Study 33368399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of volume as predictor for smaller lesions and selected features for larger lesions
Number of subjects: 150
Study 33368399 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected radiomic features for smaller lesions
Number of subjects: 150
Study 32392748 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular siesta practice
Number of subjects: 194
Study 32392748 — intervention group
Group type: COMPARATOR
Intervention: Hypertension
Number of subjects: 194
Study 32392748 — intervention group
Group type: COMPARATOR
Intervention: Diabetes mellitus
Number of subjects: 194
Study 32392748 — intervention group
Group type: COMPARATOR
Intervention: Excess body weight (BMI > 25 kg/m2)
Number of subjects: 194
Study 32392748 — intervention group
Group type: COMPARATOR
Intervention: Dyslipidemia
Number of subjects: 194
Study 36401615 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage surgery after locoregional failure (LRF)
Number of subjects: 61
Study 36401615 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage surgery after LRF
Number of subjects: 61
Study 32722652 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 55
Study 32722652 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 55
Study 32722652 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Training (CT = HIIT + RT)
Number of subjects: 55
Study 32722652 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional Guidance (NG)
Number of subjects: 55
Study 36206888 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery focussed cognitive therapy (ImCT)
Number of subjects: 62
Study 36206888 — intervention group
Group type: COMPARATOR
Intervention: Group psychoeducation (PE)
Number of subjects: 62
Study 33942423 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT-I)
Number of subjects: 276
Study 34961942 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8% HA gel applied onto the collagen matrix three times per day for 7 days
Number of subjects: 38
Study 34961942 — intervention group
Group type: COMPARATOR
Intervention: No gel application
Number of subjects: 38
Study 32599670 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-12 week exercise intervention
Number of subjects: 30
Study 32599670 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 30
Study 34802922 — intervention group
Group type: EXPERIMENTAL
Intervention: ISBAR structured dialogue tool
Number of subjects: 50
Study 33216408 — intervention group
Group type: EXPERIMENTAL
Intervention: CCT combined with tDCS targeting left dorsolateral prefrontal cortex (1 mA)
Number of subjects: 77
Study 33216408 — intervention group
Group type: COMPARATOR
Intervention: CCT combined with sham tDCS (40s active stimulation, 1 mA)
Number of subjects: 77
Study 33216408 — intervention group
Group type: EXPERIMENTAL
Intervention: CCT combined with tDCS
Number of subjects: 77
Study 34964449 — intervention group
Group type: EXPERIMENTAL
Intervention: SHED-IT: Recharge (n = 62)
Number of subjects: 125
Study 34964449 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 63)
Number of subjects: 125
Study 32242400 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-blossom needling
Number of subjects: 0
Study 32242400 — intervention group
Group type: COMPARATOR
Intervention: Tropicamide eye drops
Number of subjects: 0
Study 35320176 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour hypnotherapy (3 months duration)
Number of subjects: 60
Study 35320176 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 60
Study 32748456 — intervention group
Group type: EXPERIMENTAL
Intervention: AAE form
Number of subjects: 206
Study 32748456 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoApp
Number of subjects: 206
Study 36356411 — intervention group
Group type: EXPERIMENTAL
Intervention: PALLI-COM communication skills training (2 × 90 min)
Number of subjects: 141
Study 36356411 — intervention group
Group type: EXPERIMENTAL
Intervention: PALLI-COM communication skills training
Number of subjects: 141
Study 36356411 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group (CG)
Number of subjects: 141
Study 32079526 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP individually titrated, guided by an analysis of the intratidal compliance profile
Number of subjects: 60
Study 32079526 — intervention group
Group type: COMPARATOR
Intervention: PEEP 5 cmH2O (control group)
Number of subjects: 60
Study 32079526 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of respiratory mechanics and hemodynamic variables
Number of subjects: 60
Study 32079526 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance profile analysis
Number of subjects: 60
Study 36396084 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (660nm, 400mW/cm2, 300 seconds, methylene blue 0.01%)
Number of subjects: 34
Study 36396084 — intervention group
Group type: COMPARATOR
Intervention: Mupirocin (twice a day for 5 days)
Number of subjects: 34
Study 36396084 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy
Number of subjects: 34
Study 36396084 — intervention group
Group type: COMPARATOR
Intervention: Mupirocin
Number of subjects: 34
Study 34213868 — intervention group
Group type: EXPERIMENTAL
Intervention: CT navigation percutaneous spinal endoscopy
Number of subjects: 68
Study 34213868 — intervention group
Group type: COMPARATOR
Intervention: Open discectomy
Number of subjects: 68
Study 35082136 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 291448
Study 35082136 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Number of subjects: 291448
Study 35082136 — intervention group
Group type: COMPARATOR
Intervention: No intervention (proactive management)
Number of subjects: 291448
Study 33074590 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg/d
Number of subjects: 206
Study 33074590 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 206
Study 32520140 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon catheter
Number of subjects: 0
Study 32520140 — intervention group
Group type: COMPARATOR
Intervention: Metal cannula
Number of subjects: 0
Study 35484927 — intervention group
Group type: EXPERIMENTAL
Intervention: Starch- and sucrose-reduced diet (SSRD) for 4 weeks
Number of subjects: 80
Study 35484927 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet), n = 25
Number of subjects: 80
Study 34542305 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/Salmeterol (FP/Salm) with as-needed short acting beta-2 agonist (SABA)
Number of subjects: 7787
Study 34542305 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/Formoterol (BUD/Form) Maintenance And Reliever Therapy (MART)
Number of subjects: 7787
Study 33596833 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitive cardiac troponin I (hs-cTnI) measurement at presentation
Number of subjects: 3295
Study 33596833 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitive cardiac troponin I (hs-cTnI) measurement
Number of subjects: 3295
Study 32532631 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidermal grafting (EG)
Number of subjects: 44
Study 32532631 — intervention group
Group type: COMPARATOR
Intervention: Split thickness skin grafting (SSG)
Number of subjects: 44
Study 36102582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided anterior quadratus lumborum block (LAL-QLB) with intravenous analgesia
Number of subjects: 74
Study 32505867 — intervention group
Group type: EXPERIMENTAL
Intervention: LED-based stimulation systems (FSA 10® and Lifeline® stimulators)
Number of subjects: 39
Study 32505867 — intervention group
Group type: COMPARATOR
Intervention: Grass PS 33 xenon lamp device
Number of subjects: 39
Study 34626891 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet dissonance-based intervention (DBI-I)
Number of subjects: 278
Study 32548702 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-related autoantibodies (ICA, IAA, GADA, IA-2A, ZnT8A)
Number of subjects: 2159
Study 35689673 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis (DBT)
Number of subjects: 73866
Study 33035148 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning program (15-min duration)
Number of subjects: 50
Study 33035148 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 50
Study 33130570 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (4×4 min at 75%-85% peak power output)
Number of subjects: 60
Study 33130570 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training (25 min at 55%-65% peak power output)
Number of subjects: 60
Study 33130570 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (whole body, 3 sets of 6-12 repetitions at 70%-90% one repetition maximum)
Number of subjects: 60
Study 33130570 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 60
Study 33130570 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 60
Study 33654240 — intervention group
Group type: EXPERIMENTAL
Intervention: Ownership of home blood pressure monitor (HBPM)
Number of subjects: 21104
Study 33654240 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 21104
Study 33654240 — intervention group
Group type: EXPERIMENTAL
Intervention: Residing in a less deprived socioeconomic region (IMD Decile 6–10)
Number of subjects: 21104
Study 33654240 — intervention group
Group type: EXPERIMENTAL
Intervention: History of diabetes mellitus
Number of subjects: 21104
Study 33654240 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers compared to non-smokers
Number of subjects: 21104
Study 34130617 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct angiographic intervention for selected patients
Number of subjects: 0
Study 34130617 — intervention group
Group type: COMPARATOR
Intervention: Endovascular thrombectomy
Number of subjects: 0
Study 32675229 — intervention group
Group type: EXPERIMENTAL
Intervention: myPlan Kenya (intervention)
Number of subjects: 352
Study 32675229 — intervention group
Group type: COMPARATOR
Intervention: Standard IPV referrals (control)
Number of subjects: 352
Study 34251949 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media-based support via WhatsApp
Number of subjects: 68
Study 34251949 — intervention group
Group type: COMPARATOR
Intervention: Routine breastfeeding teaching
Number of subjects: 68
Study 34839993 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 3
Study 34839993 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 3
Study 34839993 — intervention group
Group type: COMPARATOR
Intervention: PPSV23
Number of subjects: 3
Study 35784225 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention approach 2 (FGD/KI and information on animal health)
Number of subjects: 325
Study 35784225 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention approach 3 (FGD/KII and information package on animal health plus information on AMR)
Number of subjects: 325
Study 35784225 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention meetings
Number of subjects: 325
Study 35784225 — intervention group
Group type: EXPERIMENTAL
Intervention: Female farmers
Number of subjects: 325
Study 35784225 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterinary professionals
Number of subjects: 325
Study 34049123 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertiveness training only
Number of subjects: 93
Study 34049123 — intervention group
Group type: EXPERIMENTAL
Intervention: SBAR technique only
Number of subjects: 93
Study 34049123 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of assertiveness training and SBAR technique
Number of subjects: 93
Study 35279333 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education via mobile applications
Number of subjects: 214
Study 35279333 — intervention group
Group type: COMPARATOR
Intervention: Routine face-to-face education (Control)
Number of subjects: 214
Study 34083388 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 210
Study 34083388 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 210
Study 34083388 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 210
Study 34083388 — intervention group
Group type: EXPERIMENTAL
Intervention: All three drugs
Number of subjects: 210
Study 32909660 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Number of subjects: 64
Study 34792871 — intervention group
Group type: EXPERIMENTAL
Intervention: IPT‐BPD‐R
Number of subjects: 43
Study 34792871 — intervention group
Group type: COMPARATOR
Intervention: Waiting list with clinical management
Number of subjects: 43
Study 34687986 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital email adherence intervention
Number of subjects: 30
Study 34687986 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 34687986 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 30
Study 36104740 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention (ManGuard)
Number of subjects: 30
Study 36104740 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study 35197082 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (20 mg/kg, administered intravenously in 2 doses early postnatally and 3 doses perioperatively)
Number of subjects: 236
Study 35197082 — intervention group
Group type: COMPARATOR
Intervention: Mannitol-placebo (control group)
Number of subjects: 236
Study 35197082 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 236
Study 32029498 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg TXA
Number of subjects: 0
Study 32029498 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0
Study 34298279 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 204
Study 34298279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204